Search

everythinglearnresearchcommunity

for

Search:↓

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Abnormal growth factor metabolism may link psoriasis and metabolic syndrome, and obesity can affect psoriasis treatment effectiveness.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

Alopecia areata in Dubai mostly affects men, often involves autoimmune disorders, and has high healthcare costs, especially for psychological issues.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

A young boy with Netherton syndrome improved significantly using IVIG, dupilumab, and dietary changes.

Plaquenil can cause a severe skin reaction called AGEP, requiring prompt diagnosis and treatment.

Dermatology drug use in Denmark mostly follows expected patterns, but further checks are needed for any misuse.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

New and repurposed treatments are improving outcomes in dermatology.

Improving education, training, and access to affordable treatments is crucial for better managing inflammatory skin diseases in Latin America.

New guidelines and referral pathways for skin conditions aim to improve care and referrals in Pakistan.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

Isotretinoin effectively improved severe pityriasis rubra pilaris with complications.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.